20096 ⎘
Medicinal preparations characterised by special physical form; Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Controlled release system and manufacturing method thereof
#3902Stabilization of Biologically Active Proteins With Mixtures of Polysaccharides and Amino Acid Based Compounds
#3903Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
#3904Method and System for in Vivo Drug Delivery
#3905CLOSTRIDIAL TOXIN PHARMACEUTICAL COMPOSITIONS
#3906MUSCLE CONTRACTION TREATMENT UTILIZING BOTULINUM TOXIN
#3907Protein Formulations Containing Sorbitol
#3908Pharmaceutical Formulations Comprising Incretin Peptide and Aprotic Polar Solvent
#3909Pharmaceutical Compositions Preparation of Peptides, Secreted by the Snake Venom Glands, Particularly of Bothrops Jararaca, Vasopeptidases Inhibitors, Evasins, Their Analogues, Derivatives and Products Associated, Thereof, for Development of Applications and Use in Chronic-Degenerative Diseases
#3910Allergen dosage form
#3911Stable liquid IL-1 antagonist formulations
#3912Lyophilized formulations of Salinosporamide A
#3913Allergen dosage form
#3914Albumin-free factor VIII formulations
#3915Gas-containing liposomes
#3916Lyophilisation targeting defined residual moisture by limited desorption energy levels
#3917Methods for Obtaining a Fast Dissolving Imidapril Powder
#3918Injectable Depot Formulations And Methods For Providing Sustained Release Of Poorly Soluble Drugs Comprising Nanoparticles
#3919Medical compositions for intravesical treatment of bladder cancer
#3920Lyophilised Preparation Comprising Antibodies Against The EFG Receptor
#3921Biguanide Composition and Method of Treatment and Prevention of Infections
#3922FORMULATIONS USEFUL FOR IMMUNOTHERAPY FOR CANCERS CONTAINING BACTERIAL COMPONENT AS AN ACTIVE INGREDIENT
#3923Protein stabilization formulations
#3924MICELLAR DRUG DELIVERY VEHICLES AND PRECURSORS THERETO AND USES THEREOF
#3925Glp-1 analogue formulations
#3926Medicinal Composition and Process for Producing the Same
#3927Ophthalmic Nanoparticulate Formulation Of A Cyclooxygenase-2 Selective Inhibitor
#3928Bioresorbable Fillers Constituted by Phospholipid Liposomes and Hyaluronic Acid and/or the Derivatives Thereof
#3929High Protein Concentration Formulations Containing Mannitol
#3930MICELLAR DRUG DELIVERY VEHICLES AND PRECURSORS THERETO AND USES THEREOF
#3931Enhanced immediate release formulations of topiramate
#3932Stable Formulations Of Peptides
#3933Controlled-release formulations
#3934METHODS AND FORMULATIONS FOR ENHANCING THE ABSORPTION AND DECREASING THE ABSORPTION VARIABILITY OF ORALLY ADMINISTERED DRUGS, VITAMINS AND NUTRIENTS
#3935Stable polypeptide formulations
#3936Bis(thiohydrazide amides) formulation
#3937Photochemical therapy to affect mechanical and/or chemical properties of body tissue
#3938Modified human growth hormone formulations with an increased serum half-life
#3939Formulations of Human Growth Hormone Comprising a Non-Naturally Encoded Amino Acid
#3940Formulations of human growth hormone comprising a non-naturally encoded amino acid
#3941Controlled release sterile injectable aripiprazole formulation and method
#3942Controlled release sterile injectable aripiprazole formulation and method
#3943Preservation of bioactive materials by freeze dried foam
#3944Stable formulations
#3945Preparation of formulations of angiotensin II AT1 receptors antagonists for the treatment of arterial hypertension, other cardiovascular illnesses and its complications
#3946PHARMACEUTICAL COMPOSITIONS CONTAINING BOTULINUM TOXIN
#3947Water-dispersible oral, parenteral, and topical formulations for poorly water soluble drugs using smart polymeric nanoparticles
#3948Controlled release sterile injectable aripiprazole formulation and method
#3949Combination Chemotherapy Comprising A Liposomal Platinum Complex
#3950Sustained release intraocular drug delivery systems comprising a water soluble therapeutic agent and a release modifier
#3951Modified Human Growth Hormone
#3952Liquid adenovirus formulations
#3953CEPHALOSPORIN DERIVATIVE FORMULATION
#3954Freeze-Dried Composition of Inactivated Virus Envelope with Membrane Fusion Activity
#3955Formulation for adenovirus storage
#3956Modified-release microparticles based on amphiphilic copolymer and on active principles(s) and pharmaceutical formulations comprising them
#3957Modified human growth hormone
#3958Modified Human Growth Hormone
#3959Parenteral Forms Of Administration Of Imexon And Method For The Production Thereof
#3960Method of Stabilizing Disordered Cefovecin Sodium Salt
#3961Prosaposin as a neurotrophic factor
#3962Methods and compositions for treatment of sleep apnea
#3963Medical compositions containing ghrelin
#3964Formulations of sitaxsentan sodium
#3965Pharmaceutical formulation
#3966Permucosal Composition and Method of Improving Permucosal Absorption
#3967Methods for reducing protein aggregation
#3968Composition of a polypeptide and an amphiphilic compound in an ionic complex and the use thereof
#3969Dry powder compound formulations and uses thereof
#3970VACCINE
#3971Immunogenic composition of a homogeneous live attenuated human rotavirus population
#3972Dry compositions
#3973Pharmaceutical composition comprising botulinum, a non ionic surfactant, sodium chloride and sucrose
#3974Microparticles for Oral Delivery
#3975Dried blood factor composition comprising trehalose
#3976New Indications for Direct Thrombin Inhibitors in the Cardiovascular Field
#3977Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes
#3978Dry powder formulations of antihistamine for nasal administration
#3979Stabilized Freeze-Dried Formulation for Cephalosporin Derivatives
#3980Pharmaceutical Preparation Containing Bacterial Cell Wall Skeleton
#3981Bioimplant formulation comprising lecithin and stearin
#3982High dose orally dissolvable/disintegrable lyophilized dosage form
#3983Orally dissolvable/disintegrable lyophilized dosage forms containing protected
#3984HUMAN LYSOZYME MEDICINE, ITS MANUFACTURING METHOD AND APPLICATION THEREOF
#3985Powdered Compositions Of Sensitive Active Materials In An At Least Partially Amorphous State
#3986Stable Aqueous G-Csf Conatining Compositions
#3987Combination Chemotherapy Comprising a Gemcitabine and a Liposomal Platium Complex
#3988Combination Chemotherapy Comprising Capecitabine and a Liposomal Platinum Complex
#3989Pharmaceutical compositions for sustained release delivery of peptides
#3990Clostridium botulinum c3 exotransferase compositions and methods for treating tumour spreading
#3991IL-1 antagonist formulations
#3992Amorphous pregabalin and process for the preparation thereof
#3993Therapeutic agent for type II diabetes comprising protease-inhibiting compound
#3994Methods for pulmonary delivery of interleukin-2
#3995P277 PEPTIDE FORMULATIONS OR VARIANTS THEREOF HAVING OPTIMIZED STABILITY
#3996Lyophilisate Comprising N-Diaminomethylene-2-Methyl-4,5-Di(Methylsulfonyl)Benzamide
#3997Crystalline forms of a biphenyl compound
#3998Stabilizing alkylglycoside compositions and methods thereof
#3999VEGF antagonist formulations suitable for intravitreal administration
#4000Enhanced delivery of drug compositions to treat life threatening infections
#4001Use of Ulinastatin and its pharmaceutical composition for treating severe acute respiratory syndrome
#4002Botulinum toxin formulation for oral administration
#4003Methods for the treatment of macular degeneration and related eye conditions
#4004Method of stabilizing proteins
#4005Stabilized pentosan polysulfate (PPS) formulations and methods of analyzing them
#4006Oral administration of calcitonin
#4007Amniotic membrane preparations and purified compositions and anti-inflammation methods
#4008Glucagon-like-peptide-2 (GLP-2) analogues
#4009Botulinum toxin neurotoxic component for treating juvenile cerebral palsy
#4010Compositions and methods for treating collagen-mediated diseases
#4011COMPOSITIONS CAPABLE OF FACILITATING PENETRATION ACROSS A BIOLOGICAL BARRIER
#4012Methods for facilitating weight loss
#4013Aerosolized fosfomycin/aminoglycoside combination for the treatment of bacterial respiratory infections
#4014Formulations for ecallantide
#4015Composition containing benzamidine derivative and method for stabilizing benzamidine derivative
#4016Stabilised solid compositions of factor VII polypeptides
#4017PHARMACEUTICAL COMPOSITIONS AND METHODS TO ACHIEVE AND MAINTAIN A TARGETED AND STABLE COPPER STATUS AND PREVENT AND TREAT COPPER-RELATED CENTRAL NERVOUS SYSTEM DISEASES
#4018Vitamin E succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
#4019Freeze-dried product of N-[o-(p-pivaloyloxy benzenesulfonylamino)benzoyl]glycine monosodium salt tetra-hydrate and a process for the manufacture thereof
#4020GRF-containing lyophilized pharmaceutical compositions
#4021Oral formulations of cladribine
#4022Stabilized compositions of proteins having a free thiol moiety
#4023Agent for substitution of blood plasma and a method of its production
#4024THERMOSENSITIVE AND BIODEGRADABLE MICROGEL AND A METHOD FOR THE PREPARATION THEREOF
#4025DEPOT COMPOSITIONS WITH MULTIPLE DRUG RELEASE RATE CONTROLS AND USES THEREOF
#4026Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
#4027Injectable composition
#4028Technology for preparation of macromolecular microspheres
#4029Esters of L-carnitine or alkanoyl L-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds
#4030Method for preparation of microsphere and apparatus therefor
#4031Pharmaceutical Formulation
#4032PROCESSES FOR MAKING PARTICLE-BASED PHARMACEUTICAL FORMULATIONS FOR PARENTERAL ADMINISTRATION
#4033Preparations of growth hormone
#4034Liposomal compositions
#4035Pharmaceutical compositions and methods for treating oxalate-dependent conditions
#4036Method of administering porcine B-domainless fVIII
#4037Compositions capable of facilitation penetration across a biological barrier
#4038Methods of treating hepatocellular carcinoma with denspm
#4039Dried blood factor composition comprising trehalose
#4040Peptide/Lipid Complex Formation by Co-Lyphilization
#4041Anionic hydrogel matrices with ph dependent modified release as drug carriers
#4042Protein-Stabilized Liposomal Formulations of Pharmaceutical Agents
#4043Methods for making Apo-2 ligand using divalent metal ions
#4044Haemostatic sprays and compositions
#4045Composition for medical use having improved water-solubility of peptide and metal-labeling efficiency and preparation for medical use comprising metal-labeled peptide
#4046Anthrax vaccines and delivery methods
#4047EDIBLE VACCINE
#4048Oral, Pulmonary and Transmucosal Delivery Composition
#4049Therapeutic formulation
#4050Lyophilized compositions of a triazolopyrimidine compound
#4051Sodium chloride solution for drug reconstitution or dilution
#4052COMPOSITIONS OF LIPOXYGENASE INHIBITORS
#4053POLYPEPTIDES WITH THE CAPACITY TO ENTRAP DRUGS AND RELEASE THEM IN A CONTROLLED WAY
#4054Drug-delivering composite structures
#4055COMPOSITIONS AND METHODS OF DELIVERY OF PHARMACOLOGICAL AGENTS
#4056Treatment and prevention of asthma
#4057Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
#4058Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
#4059Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
#4060Probiotic storage and delivery
#4061Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
#4062Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
#4063Methods of treating chemotherapy-induced diarrhea/mucositis using glucagon-like-peptide-2(GLP-2)analogues
#4064Compositions comprising poorly water soluble pharmaceutical agents and antimicrobial agents
#4065Tazobactam/piperacillin lyophilizate
#4066Sustained release preparations composed of biocompatible complex microparticles
#4067Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
#4068Lyophilization process and products obtained thereby
#4069Antibiotic formulations, unit doses, kits, and methods
#4070Crystalline forms of a biphenyl compound
#4071COMPOSITIONS COMPRISING LIPOXYGENASE INHIBITORS AND CYCLODEXTRIN
#4072Peptide pharmaceutical compositions
#4073Antibody formulations having optimized aggregation and fragmentation profiles
#4074Dry recombinant human alpha 1-antitrypsin formulation
#4075Polymeric delivery formulations of leuprolide with improved efficacy
#4076Thrombin compositions
#4077Synthesis of R-N-methylnaltrexone
#4078PROCESS FOR PREPARING FORMULATIONS OF LYPOPHILIC ACTIVE SUBSTANCES BY SPRAY FREEZING DRYING
#4079Novel IV formulation of tipifarnib
#4080Pharmaceutical compositions containing cyclodextrins and taxoids
#4081Methods of treating IgE-mediated disorders comprising the administration of high concentration anti-IgE antibody formulations
#4082Formulations of AICA riboside
#4083Compositions and methods for preparation of poorly water soluble drugs with increased stability
#4084Particle size reduction of bioactive compounds
#4085Pharmaceutical compositions containing botulinum toxin
#4086Particulate acellular tissue matrix
#4087Purified amniotic membrane compositions and methods of use
#4088Novel Dry Powder Inhalation System For Transpulmonary Administration
#4089Organic compounds
#4090Freeze-dried FSH/LH formulations
#4091Process for co-spray drying liquid herbal extracts with dry silicified MCC
#4092Pharmaceutical formulations
#4093Nanocell drug delivery system
#4094Glycopeptide phosphonate derivatives
#4095Methods and compositions using gonadotropin hormone releasing hormone
#4096Stable aqueous solutions of granulocyte macrophage colony-stimulating factor
#4097Use of recombinant or synthetic gelatin-like proteins as stabiliser in lyophilized pharmaceutical compositions
#4098Stabilizers for veterinary vaccines
#4099Manufacturing process for tigecycline
#4100Botulinum toxin compositions
#4101Stabilized teriparatide solutions
#4102Stabilized teriparatide solutions
#4103Stabilised compositions of Factor VII
#4104Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid
#4105Preparations and processes for stabilizing biological materials by means of drying processes without freezing
#4106Method of emulsifying phytosterol by natural saponin,emulsion prepared thereby and water dispersible phytosterol powder product
#4107Immuno-adjuvant emulsion
#4108Medical Compositions for Intravesical Treatment of Bladder Cancer
#4109Drug conjugate composition
#4110Drug conjugate composition
#4111Drug conjugate composition
#4112Stable lyophilized anthracycline glycosides
#4113Stable, buffered, pharmaceutical compositions including motilin-like peptides
#4114Hybrid polypeptides having glucose lowering activity
#4115Pharmaceutical compositions comprising an active agent and chitosan for sustained drug release or mucoadhesion
#4116Stable pharmaceutical compositions including motilin-like peptides
#4117Stable antibody formulation
#4118Novel treatment for pathological aggression
#4119Pharmaceutical composition, method of manufacturing and therapeutic use thereof
#4120Suspension formulation of interferon
#4121Pharmaceutical compositions of fibrinolytic agent
#4122Sustained-release microparticle preparation of human growth hormone and process for producing thereof
#4123Coated tablets
#4124Drug delivery systems for stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof
#4125Flupirtin injectable galenic form
#4126Implantable device for continuous delivery of interferon
#4127Compositon useful for delivery of active agents
#4128Method for stabilizing a cryoprecipitate of plasmatic proteins for being subjected to a viral inactivation thermal treatment
#4129Freeze-dried preparation containing methylcobalamin and process for producing the same
#4130Tigecycline compositions and methods of preparation
#4131Nanoparticles from biopolymers
#4132Pharmaceutical compositions of fibrinolytic agent
#4133Injectable bulking agent compositions
#4134Methods and formulations of taxanes
#4135Method for producing preparation containing bioactive substance
#4136Polymeric micelles for drug delivery
#4137Alginate sponge and preparation method thereof
#4138Novel compounds
#4139Lyophilized HGF preparations
#4140Sustained release of microcrystalline peptide suspensions
#4141Sustained release of microcrystalline peptide suspensions
#4142Active specific immunotherapy of cancer metastasis
#4143Absorption enhancers such as e.g. BHT, BHA or propyl gallate
#4144VEGF antagonist formulations
#4145Herbal compositions useful in cancer treatment
#4146Intracutaneous injection
#4147Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof
#4148Albumin-free factor VIII formulations
#4149Formulations and methods for delivery of growth factor analogs
#4150Hemostatic compositions containing sterile thrombin
#4151Small particle liposome aerosols for delivery of anticancer drugs
#4152Injectable pharmaceutical compositions of an anthracenedione derivative with anti-tumoral activity
#4153Stabilized, solid-state polypeptide particles
#4154Solid formulations of liquid biologically active agents
#4155Trans carotenoids, their synthesis, formulation and uses
#4156Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin
#4157Anti Aβ antibody formulation
#4158Modified human growth horomone polypeptides and their uses
#4159Stabilized pharmaceutical peptide compositions
#4160Reduction of adipose tissue
#4161Medical compositions containing ghrelin
#4162GRF-containing lyophilized pharmaceutical compositions
#4163Bendamustine pharmaceutical compositions
#4164Stabilized lyophilized compositions comprising tissue factor pathway inhibitor or tissue factor pathway inhibitor variants
#4165Formulations for IL-11
#4166Method for preparation of particles from solution-in-supercritical fluid or compressed gas emulsions
#4167Lyophilized pharmaceutical compositions
#4168Pharmaceutical formulation
#4169Formulation of human antibodies for treating TNF-α associated disorders
#4170Drug formulations having long and medium chain triglycerides
#4171Bioactive compounds protection method and compositions containing the same
#4172Liquid pharmaceutical formulations of FSH and LH together with a non-ionic surfactant
#4173Pharmaceutical compositions for nasal delivery
#4174Compositions for treating wounds and processes for their preparation
#4175Formulations of human growth hormone comprising a non-naturally encoded amino acid at position 35
#4176Process for producing sterile suspensions of slightly soluble basic peptide complexes, sterile suspensions of slightly soluble basic peptide complexes, pharmaceutical formulations containing them, and the use thereof as medicaments
#4177Oral administration of calcitonin
#4178Methods for producing block copolymer/amphiphilic particles
#4179Complexes made using low solubility drugs
#4180Compositions and methods for treating tumor spreading
#4181Therapeutic formulations of keratinocyte growth factor
#4182Composition for enzyme inhibition
#4183Organic compounds
#4184Processes of making and using pharmaceutical formulations of antineoplastic agents
#4185Uptake of macromolecules
#4186Hazard-free microencapsulation for structurally delicate agents, an application of stable aqueous-aqueous emulsion
#4187Methods and compositions for tissue regeneration
#4188Lyophilized azithromycin formulation
#4189Lyophilized liposome formulations and method
#4190Hemostatic compositions containing sterile thrombin
#4191Clostridial toxin pharmaceutical composition containing a gelatin fragment
#4192Polysaccharide containing botulinum toxin pharmaceutical compositions and uses thereof
#4193Pharmaceutical formulations of ecteinascidin compounds
#4194Stable thrombin composition
#4195High-concentration preparation of soluble thrombomodulin
#4196Purified LH
#4197Hydroxyethyl starch-containing polypeptide compositions
#4198Dry polymer and lipid composition
#4199Dry powder inhalation system for transpulmonary administration
#4200Lyophilized pharmaceutical compositions